Robuta

https://english.cbg-meb.nl/latest/news/2021/09/24/year-end-withdrawals-medicines-for-human-use Year-end withdrawals medicines for human use | Medicines Evaluation Board Requests to withdraw marketing authorisations and parallel import marketing authorisations as of 31 December 2021, the so-called 'year-end withdrawals' for... medicines for human useyear endwithdrawalsevaluationboard https://english.cbg-meb.nl/sections/marketing-authorisation-medicines-for-human-use Marketing authorisation medicines for human use | Medicines Evaluation Board The MEB Application compass facilitates your application. Dutch medicines for human usemarketing authorisationevaluationboard https://www.sfee.gr/en/supplementary-price-bulletin-of-medicines-for-human-use-due-to-voluntary-reductions-05-10-2020/ Supplementary Price Bulletin of Medicines for Human Use due to voluntary reductions (05.10.2020) |... Mar 13, 2024 - Supplementary Price Bulletin of Medicines for Human Use due to voluntary reductions and will enter into force on 05.10.2020 medicines for human use https://www.ema.europa.eu/en/committees/committee-medicinal-products-human-use-chmp Committee for Medicinal Products for Human Use (CHMP) | European Medicines Agency (EMA) Apr 24, 2026 - The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency's (EMA) committee responsible for human medicines. It plays a vital... european medicines agencymedicinal productshuman usecommittee